Old Web
English
Sign In
Acemap
>
Paper
>
P84.03 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients
P84.03 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients
2021
N. Peled
Roni Gillis
Sadettin Kilickap
Patrizia Froesch
S. Orlov
Elena Filippova
Umut Demirci
Petros Christopoulos
Irfan Cicin
F Bugdayci Basal
Cengiz Yilmaz
M. Fedor
Taner Korkmaz
Saime Paydas
Oliver Gautschi
A. Zirtiloglu
Yesim Eralp
Havva Yeşil Çınkır
Ahmet Sezer
Mustafa Erman
Deniz Tural
Hande Turna
Julien Mazieres
Elizabeth Dudnik
Noemi Reguart
R. Camidge
Terry L. Ng
F. Çay Şenler
Ismail Beypinar
Dogan Yazilitas
A. Demirkazik
Aziz Karaoglu
K. Okutur
H. Senol Coskun
M.A. Nahit Şendur
Abdurrahman Isikdogan
Devrim Cabuk
Perran Fulden Yumuk
Ibrahim Yildiz
Muhammet Ali Kaplan
Ozgur Ozyilkan
Ilhan Oztop
O.F. Olmez
Kübra Aydın
Adnan Aydiner
Nezih Meydan
R. Grinberg
L. Roisman
Keywords:
Medical physics
Lorlatinib
real world data
ROS1
Medicine
Retrospective cohort study
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]